Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Soft signs in movement disorders: friends or foes?

Fearon C, Espay AJ, Lang AE, Lynch T, Martino D, Morgante F, Quinn NP, Vidailhet M, Fasano A.

J Neurol Neurosurg Psychiatry. 2018 Nov 8. pii: jnnp-2018-318455. doi: 10.1136/jnnp-2018-318455. [Epub ahead of print] No abstract available.

PMID:
30409889
2.

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, Biedenharn J, Bitan G, Brooks DJ, Brundin P, Fernandez H, Fortier P, Freeman R, Gasser T, Hewitt A, Höglinger GU, Huentelman MJ, Jensen PH, Jeromin A, Kang UJ, Kaufmann H, Kellerman L, Khurana V, Klockgether T, Kim WS, Langer C, LeWitt P, Masliah E, Meissner W, Melki R, Ostrowitzki S, Piantadosi S, Poewe W, Robertson D, Roemer C, Schenk D, Schlossmacher M, Schmahmann JD, Seppi K, Shih L, Siderowf A, Stebbins GT, Stefanova N, Tsuji S, Sutton S, Zhang J.

Neurology. 2018 Jan 9;90(2):74-82. doi: 10.1212/WNL.0000000000004798. Epub 2017 Dec 13. Review.

PMID:
29237794
3.

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A.

Qual Life Res. 2016 Jan;25(1):81-8. doi: 10.1007/s11136-015-1071-y. Epub 2015 Aug 12.

PMID:
26264781
4.

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.

Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):319-23. doi: 10.1136/jnnp-2014-310256. Epub 2015 May 19. Review.

PMID:
25991401
5.

The effect of bottom roughness on scalar transport in aquatic ecosystems: implications for reproduction and recruitment in the benthos.

Quinn NP, Ackerman JD.

J Theor Biol. 2015 Mar 21;369:59-66. doi: 10.1016/j.jtbi.2015.01.007. Epub 2015 Jan 14.

PMID:
25596514
6.

H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?

Erro R, Hersheson J, Ganos C, Mencacci NE, Stamelou M, Batla A, Thust SC, Bras JM, Guerreiro RJ, Hardy J, Quinn NP, Houlden H, Bhatia KP.

Mov Disord. 2015 May;30(6):828-33. doi: 10.1002/mds.26129. Epub 2014 Dec 27.

PMID:
25545912
7.
8.

The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.

Romano D, Maccario H, Doherty C, Quinn NP, Kolch W, Matallanas D.

Mol Cell Biol. 2013 May;33(9):1859-68. doi: 10.1128/MCB.01414-12. Epub 2013 Mar 4.

9.

Does rest tremor exclude the diagnosis of adult-onset primary dystonia?

Erro R, Quinn NP, Schneider SA, Bhatia KP.

J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):708. doi: 10.1136/jnnp-2012-304779. Epub 2013 Feb 13. No abstract available.

PMID:
23408067
10.

The natural history of multiple system atrophy: a prospective European cohort study.

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W; European Multiple System Atrophy Study Group.

Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5.

11.

The Unified Multiple System Atrophy Rating Scale: intrarater reliability.

Krismer F, Seppi K, Tison F, Sampaio C, Zangerl A, Peralta C, Yekhlef F, Ghorayeb I, Ory-Magne F, Galitzky M, Bozi M, Scaravilli T, Colosimo C, Geser F, Rascol O, Poewe W, Quinn NP, Wenning GK; European Multiple System Atrophy Study Group.

Mov Disord. 2012 Nov;27(13):1683-5. doi: 10.1002/mds.25181. Epub 2012 Oct 31.

12.

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.

Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Oertel WH, Björklund A, Lindvall O, Piccini P.

Sci Transl Med. 2012 Apr 4;4(128):128ra41. doi: 10.1126/scitranslmed.3003391.

13.

On the nature of fear of falling in Parkinson's disease.

Rahman S, Griffin HJ, Quinn NP, Jahanshahi M.

Behav Neurol. 2011;24(3):219-28. doi: 10.3233/BEN-2011-0330.

14.

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

Politis M, Oertel WH, Wu K, Quinn NP, Pogarell O, Brooks DJ, Bjorklund A, Lindvall O, Piccini P.

Mov Disord. 2011 Sep;26(11):1997-2003. doi: 10.1002/mds.23743. Epub 2011 May 24.

PMID:
21611977
15.

Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment.

Ruge D, Tisch S, Hariz MI, Zrinzo L, Bhatia KP, Quinn NP, Jahanshahi M, Limousin P, Rothwell JC.

Mov Disord. 2011 Aug 15;26(10):1913-21. doi: 10.1002/mds.23731. Epub 2011 May 5.

16.

Tremor--some controversial aspects.

Quinn NP, Schneider SA, Schwingenschuh P, Bhatia KP.

Mov Disord. 2011 Jan;26(1):18-23. doi: 10.1002/mds.23289. Epub 2010 Dec 10.

PMID:
21322015
17.

The effect of real and virtual visual cues on walking in Parkinson's disease.

Griffin HJ, Greenlaw R, Limousin P, Bhatia K, Quinn NP, Jahanshahi M.

J Neurol. 2011 Jun;258(6):991-1000. doi: 10.1007/s00415-010-5866-z. Epub 2011 Jan 9.

PMID:
21221626
18.

Nonmotor symptoms in Parkin gene-related parkinsonism.

Kägi G, Klein C, Wood NW, Schneider SA, Pramstaller PP, Tadic V, Quinn NP, van de Warrenburg BP, Bhatia KP.

Mov Disord. 2010 Jul 15;25(9):1279-84. doi: 10.1002/mds.22897.

PMID:
20629119
19.

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P.

Sci Transl Med. 2010 Jun 30;2(38):38ra46. doi: 10.1126/scitranslmed.3000976.

20.

A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy.

Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M.

Mov Disord. 2010 Jun 15;25(8):1077-81. doi: 10.1002/mds.22794.

PMID:
20535826
21.

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Schneider SA, Paisan-Ruiz C, Quinn NP, Lees AJ, Houlden H, Hardy J, Bhatia KP.

Mov Disord. 2010 Jun 15;25(8):979-84. doi: 10.1002/mds.22947.

PMID:
20310007
22.

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE.

Mov Disord. 2010 Apr 15;25(5):578-86. doi: 10.1002/mds.22735.

PMID:
20213817
23.

Reckless generosity in Parkinson's disease.

O'Sullivan SS, Evans AH, Quinn NP, Lawrence AD, Lees AJ.

Mov Disord. 2010 Jan 30;25(2):221-3. doi: 10.1002/mds.22687.

PMID:
20077470
24.

The clinical approach to movement disorders.

Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR.

Nat Rev Neurol. 2010 Jan;6(1):29-37. doi: 10.1038/nrneurol.2009.196. Review.

PMID:
20057497
25.

In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.

Pavese N, Moore RY, Scherfler C, Khan NL, Hotton G, Quinn NP, Bhatia KP, Wood NW, Brooks DJ, Lees AJ, Piccini P.

Exp Neurol. 2010 Mar;222(1):120-4. doi: 10.1016/j.expneurol.2009.12.021. Epub 2010 Jan 4.

PMID:
20043906
26.

A validation exercise on the new consensus criteria for multiple system atrophy.

Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP.

Mov Disord. 2009 Nov 15;24(15):2272-6. doi: 10.1002/mds.22826.

PMID:
19845011
27.

Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.

Pavese N, Khan NL, Scherfler C, Cohen L, Brooks DJ, Wood NW, Bhatia KP, Quinn NP, Lees AJ, Piccini P.

Mov Disord. 2009 Nov 15;24(15):2260-6. doi: 10.1002/mds.22817.

PMID:
19845000
28.

GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias.

Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, Quinn NP, Weber YG, Lerche H, Hardy J, Bhatia KP.

Mov Disord. 2009 Aug 15;24(11):1684-8. doi: 10.1002/mds.22507.

PMID:
19630075
29.

The prognosis of fixed dystonia: a follow-up study.

Ibrahim NM, Martino D, van de Warrenburg BP, Quinn NP, Bhatia KP, Brown RJ, Trimble M, Schrag A.

Parkinsonism Relat Disord. 2009 Sep;15(8):592-7. doi: 10.1016/j.parkreldis.2009.02.010. Epub 2009 May 12.

PMID:
19442561
30.

Hyposmia in pure autonomic failure.

Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ.

Neurology. 2009 May 12;72(19):1677-81. doi: 10.1212/WNL.0b013e3181a55fd2.

PMID:
19433741
31.

Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.

Sleiman PM, Healy DG, Muqit MM, Yang YX, Van Der Brug M, Holton JL, Revesz T, Quinn NP, Bhatia K, Diss JK, Lees AJ, Cookson MR, Latchman DS, Wood NW.

Neurosci Lett. 2009 Jun 26;457(2):75-9. doi: 10.1016/j.neulet.2009.03.021. Epub 2009 Mar 11.

32.

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):744-8. doi: 10.1136/jnnp.2009.172825. Epub 2009 Mar 9.

PMID:
19276101
33.

Comparative responsiveness of Parkinson's disease scales to change over time.

Schrag A, Spottke A, Quinn NP, Dodel R.

Mov Disord. 2009 Apr 30;24(6):813-8. doi: 10.1002/mds.22438.

PMID:
19199355
34.

Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome.

Wickremaratchi MM, Majounie E, Morris HR, Williams NM, Lewis H, Gill SS, Khan S, Heywood P, Hardy J, Wiles CM, Singleton AB, Quinn NP.

Mov Disord. 2009 Jan 15;24(1):138-40. doi: 10.1002/mds.22181. Review. No abstract available.

PMID:
18942080
35.

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ.

Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45.

PMID:
18809839
36.

Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp.

Koukouni V, Valente EM, Cordivari C, Bhatia KP, Quinn NP.

Mov Disord. 2008 Oct 15;23(13):1913-5. doi: 10.1002/mds.21935.

PMID:
18702114
37.

The factors that induce or overcome freezing of gait in Parkinson's disease.

Rahman S, Griffin HJ, Quinn NP, Jahanshahi M.

Behav Neurol. 2008;19(3):127-36.

38.

Quality of life in Parkinson's disease: the relative importance of the symptoms.

Rahman S, Griffin HJ, Quinn NP, Jahanshahi M.

Mov Disord. 2008 Jul 30;23(10):1428-34. doi: 10.1002/mds.21667.

PMID:
18543333
39.

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P.

Nat Med. 2008 May;14(5):501-3. doi: 10.1038/nm1746. Epub 2008 Apr 6.

PMID:
18391963
40.

Antineuronal antibodies in Parkinson's disease.

van de Warrenburg BPC, Church AJ, Martino D, Candler PM, Bhatia KP, Giovannoni G, Quinn NP.

Mov Disord. 2008 May 15;23(7):958-963. doi: 10.1002/mds.21929.

PMID:
18383532
41.

Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.

Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C; Multicentre Advanced Parkinson's Disease Deep Brain Stimulation Group.

Mov Disord. 2008 Feb 15;23(3):416-21.

PMID:
18067188
42.

Paroxysmal dyskinesia with interictal myoclonus and dystonia: a report of two cases.

De Grandis E, Mir P, Edwards MJ, Quinn NP, Bhatia KP.

Parkinsonism Relat Disord. 2008;14(3):250-2. Epub 2007 Nov 26.

PMID:
18042422
43.

The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases.

Chew NK, Mir P, Edwards MJ, Cordivari C, Martino D, Schneider SA, Kim HT, Quinn NP, Bhatia KP.

Mov Disord. 2008 Jan;23(1):107-13.

PMID:
17994572
44.

The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy.

van de Warrenburg BP, Cordivari C, Ryan AM, Phadke R, Holton JL, Bhatia KP, Hanna MG, Quinn NP.

Mov Disord. 2007 Dec;22(16):2325-31.

PMID:
17960814
45.

Measuring health-related quality of life in MSA: the MSA-QoL.

Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N, Quinn NP.

Mov Disord. 2007 Dec;22(16):2332-8.

PMID:
17914730
46.

Primary lateral sclerosis mimicking atypical parkinsonism.

Norlinah IM, Bhatia KP, Ostergaard K, Howard R, Arabia G, Quinn NP.

Mov Disord. 2007 Oct 31;22(14):2057-62.

PMID:
17702034
47.

Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene.

Kim HT, Edwards MJ, Tyson J, Quinn NP, Bitner-Glindzicz M, Bhatia KP.

Mov Disord. 2007 Jul 15;22(9):1328-31.

PMID:
17534980
48.

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study.

Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T; Growth-Hormone MSA Study Group; European MSA Study Group.

Mov Disord. 2007 Jun 15;22(8):1138-44.

PMID:
17469198
49.

Rate of clinical progression in Parkinson's disease. A prospective study.

Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP.

Mov Disord. 2007 May 15;22(7):938-45.

PMID:
17415791
50.

Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls.

Lohi H, Turnbull J, Zhao XC, Pullenayegum S, Ianzano L, Yahyaoui M, Mikati MA, Quinn NP, Franceschetti S, Zara F, Minassian BA.

Neurology. 2007 Mar 27;68(13):996-1001. Erratum in: Neurology. 2007 Jun 12;68(24):2153. Quinn, NP [added].

PMID:
17389303

Supplemental Content

Loading ...
Support Center